e-Library

Welcome to the e-library. Here you’ll find the most up-to-date scholarly materials on the Health Impact Fund, including our extensive bibliography. You can find media coverage of the Health Impact Fund here.

Our Publications

The Health Impact Fund: Making Medicines Accessible for All. Download the entire book, or click through for more downloading options, including smaller versions and individual chapters.

Health Impact Fund Brochure (PDF, 152 kb)

Health Impact Fund Summaries:

Health Impact Fund Summary in Arabic

Health Impact Fund Summary in Chinese

Health Impact Fund Summary in English

Health Impact Fund Summary in Farsi

Health Impact Fund Summary in French

Health Impact Fund Summary in German

Health Impact Fund Summar in Igbo

Health Impact Fund Summary in Spanish

Health Impact Fund Summary in Swedish

Bibliography for the Health Impact Fund

Discussion Papers

Scholarly Publications on the Health Impact Fund

Thomas Pogge, "The Health Impact Fund: Better Pharmaceutical Innovations at Much Lower Prices." SSRN Working Paper, July 2009.

IGH Submission to the WHO's Expert Working Group on R&D Financing. April 2009.

"Providing Medicines For The Poor," an exchange with Pfizer executive Philip Hedger. December 1, 2008. Chemical & Engineering News

Aidan Hollis, "Incentive Mechanisms for Innovation"

Carl Nathan, "Aligning Pharmaceutical Innovation With Medical Need." Nature Medicine, March 2007.

Thomas Pogge, "Human Rights and Global Health: A Research Program." Metaphilosophy, January 2005.

Thomas Pogge, “Medicines for the World: Boosting Innovation without Obstructing Free Access.” Sur: Revista Internacional de direitos humanos. 2008. Versions in English, Spanish, and Portuguese.

Michael Selgelid, "Improving Global Health: Counting Reasons Why" in Developing World Bioethics.

Joseph E. Stiglitz, “Scrooge and Intellectual Property Rights. A Medical Prize Fund Could Improve the Financing of Drug Innovations.” British Medical Journal, December 2006.

Thomas Pogge, "Incentives for Pharmaceutical Research – Must They Exclude the Global Poor from Advanced Medicines," speech at the workshop Access to Medicines as a Human Right: What does it Mean for Corporate Social Responsibility, University of Toronto, October 2006.

Public Health Ethics, vol. 1, no. 2, issue edited by Thomas Pogge.

Thomas Pogge, “Access to Medicines.” Public Health Ethics, June 2008.

Thomas Alured Faunce and Hitoshi Nasu, “Three Proposals for Rewarding Novel Health Technologies Benefiting People Living in Poverty. A Comparative Analysis of Prize Funds, Health Impact Funds and a Cost-Effectiveness/Competitive Tender Treaty.” May 2008.

Aidan Hollis, “The Health Impact Fund: A Useful Supplement to the Patent System?” Public Health Ethics, May 2008.

Michael Ravvin, “Incentivizing Access and Innovation for Essential Medicines: A Survey of the Problem and Proposed Solutions”. Public Health Ethics, June 2008.

Michael J. Selgelid, “A Full-Pull Program for the Provision of Pharmaceuticals: Practical Issues.” Public Health Ethics, May 2008.

Devi Sridhar, “Improving Access to Essential Medicines: How Health Concerns can be Prioritised in the Global Governance System.” Public Health Ethics, May 2008.

Other Publications

Paul Grootendorst, "How should we support pharmaceutical innovation?" SEDAP Research Paper No. 246, May 2009.